An online resource which lists low carbohydrate vegetables, beverages, condiments & sauces that are permitted on the Intensive Level of the OPTIFAST Very Low Calorie Diet Program. These additional low calorie foods can help add variety and assist in compliance for those who are utilising the OPTIFAST VLCD program. Additionally, foods that should be avoided are also listed.
Exclusive content for medical professionals and students.
OPTIFAST VLCD Intensive Level Allowed Foods
- 02/07/2021 - 10:16 am
Other content you might be interested in
OPTIFAST Patient Pre-Bariatric Surgery Diet Booklet
This online resource is a patient information booklet highlighting the VLED diet required 2 weeks before bariatric surgery including sample meal plans and recipes. This pre-bariatric surgery patient information booklet covers why the diet is necessary pre-surgery as well as some of the challenges that patients completing the VLED may come across.
OPTIFAST VLCD Protein Plus Patient Resource
An online patient brochure explaining what protein is and the importance of optimal protein intake during the process of weight loss. The brochure also outlines the key features and benefits of OPTIFAST VLCD Protein Plus Shake products and how patients can utilise the Protein Plus Shake products as part of the OPTIFAST VLCD Program.
Butsch WS et al. 2025 Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study
In this retrospective observational study it examines the increased nutritional risks in adults who undergo GLP-1 RA therapy, including those with type 2 diabetes, prediabetes, and obesity.
Supporting patient nutrition during GLP-RA therapy
Would your patients on GLP-1 RAs benefit from nutrition support? OPTIFAST VLCD products can help meet nutritional requirements when appetite is affected by GLP-1 RA therapy.
Jones et al, 2024. Real world evidence on the characteristics of regular and intermittent users of a very‐low calorie diet program and associations with measures of program success, health, and quality of life.
This study aimed to determine the demographic, eating, self‐efficacy and program engagement characteristics of VLCD users in Australia (regular vs. intermittent users) and associations with self‐perceived program success on weight loss, quality of life (QOL), mental health and physical health.
Supporting weight management following GLP-1 de-prescription
One challenge that arises after the completion of any weight loss therapy is weight regain. OPTIFAST VLCD products can be beneficial to help individuals maintain nutritional balance and reduce overall caloric intake to support continued weight management.
Clinical Paper Summary: Bacus et al, 2024. Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
This retrospective review evaluates real world clinical experience of concomitant use of meal replacement products and GLP-1 RAs in Australia and South Africa. The results illustrate that this combination for weight management is feasible in real-life and may offer potential advantages for weight management.
Vodcast. Episode 2: Weight Management Clinical Conversations (15 min)
Join Dr Mark Mellor (GP) and Dr Don Zhang (GP) for a conversation on their thoughts and experiences with weight management tools in primary care, including dietary restriction, VLEDs and GLP-1 RAs. Duration: 15 minutes.
Conley et al. 2023. Acceptability, Adherence, Safety and Experiences of Low Energy Diets in People With Obesity and Chronic Kidney Disease: A Mixed Methods Study
This research explores participant acceptability, adherence, safety, and experiences of using a short-term total diet replacement and a food-based low energy diet in adults living with chronic kidney disease and obesity.
The DiRECT-Aus Trial – Video Abstract
This video abstract provides an overview of DiRECT-Aus trial, which confirms that an intensive lifestyle intervention (very low energy diet) delivered in an Australian primary care setting results in remission of type 2 diabetes for one in two participants.
NEW! OPTIFAST Diabetes Management Guidelines 2024
The OPTIFAST Diabetes Management Guidelines have been developed to assist healthcare professionals manage patients with diabetes and excess weight who may be at greater health risk.
Intermittent Fasting Webinar
Recent years have seen a surge in popularity of eating patterns involving intermittent fasting as a way to manage and optimise health. This webinar reviews the health and physiological benefits of intermittent fasting, exploring the two most popular forms of intermittent energy restriction (The 5:2 Diet and Alternate-Day fasting).